Remove Documentation Remove Immunization Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

New RSV therapies may accelerate the emergence of resistant strains

Pharmaceutical Technology

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.